GSK plc
FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option
The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV – a milestone that the company and some experts say could help bring the world closer to ending the decades-long epidemic […]
Read More
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they’re getting closer
Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells 3d rendering Love Employee | Istock | Getty Images Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its […]
Read More
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead […]
Read More
Denmark’s economy boomed on drug exports — Trump’s tariffs threat won’t be what slows it down
Vials move along a conveyor at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Monday, June 12, 2023. The success of Novo’s bestsellers Ozempic and Wegovy, drugs that help people lose significant amounts of weight, has created something of a gold rush in the pharma industry with about 40 companies developing products that […]
Read More
European stocks open higher on China-U.S. optimism
European stocks opened higher on Friday, as investors assessed a signal that China is seeking trade negotiations will the U.S. The Stoxx 600 index jumped 0.88% in early deals, led by mining stocks, up 2.5%, while banks climbed 1.7%. Most markets were closed on Thursday for the May 1 holiday. London’s FTSE 100 ended a choppy […]
Read More
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Jgi/jamie Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Tariff threats — and efforts to get into President Donald Trump’s good graces — are fueling a new wave […]
Read More
Europe stocks open higher amid earnings deluge; autos gain on tariff hopes
European stock markets opened higher on Wednesday, as investors pored through another slew of earnings along with euro zone economic growth data. The Stoxx 600 index was up 0.44% at 8:08 a.m. in London after notching a sixth straight positive session on Tuesday, extending its longest winning streak since January. The U.K.’s FTSE 100 meanwhile closed higher […]
Read More
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S. Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% […]
Read More
The biggest winners and losers in Europe as Trump announces sweeping tariffs
U.S. President Donald Trump stands, after delivering remarks on tariffs, in the Rose Garden at the White House in Washington, D.C., U.S., April 2, 2025. Leah Millis | Reuters Global markets, businesses and long-standing geopolitical relationships were thrown into disarray on Thursday, the day after U.S. President Donald Trump’s tariff policy — and Europe was not […]
Read More
Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated […]
Read More